SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

05 Feb 2023 Evaluate
The December 2022 quarter revenue stood at Rs. 3099.70 millions, up 11.54% as compared to Rs. 2779.00 millions during the corresponding quarter last year.Profit for the quarter ended December 2022 rises by 71.28% to Rs. 768.00  millions from Rs. 448.40 millions.Operating Profit saw a handsome growth to 1149.20 millions from 665.40 millions in the quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202206 202106 % Var
Sales 3099.70 2779.00 11.54 6075.20 5507.00 10.32 11144.10 10087.30 10.48
Other Income 45.40 47.00 -3.40 79.60 77.40 2.84 131.90 181.00 -27.13
PBIDT 1149.20 665.40 72.71 2091.60 1476.50 41.66 2808.70 2641.20 6.34
Interest 2.30 1.20 91.67 3.90 2.60 50.00 4.20 8.00 -47.50
PBDT 1146.90 664.20 72.67 2087.70 1473.90 41.64 2804.50 2633.20 6.51
Depreciation 97.50 65.90 47.95 172.30 134.90 27.72 270.80 300.40 -9.85
PBT 1049.40 598.30 75.40 1915.40 1339.00 43.05 2533.70 2332.80 8.61
TAX 281.40 149.90 87.73 510.80 336.90 51.62 608.50 564.80 7.74
Deferred Tax -19.20 1.00 -2020.00 -8.90 -5.00 78.00 0.40 -49.00 -100.82
PAT 768.00 448.40 71.28 1404.60 1002.10 40.17 1925.20 1768.00 8.89
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 37.07 23.94 54.84 34.43 26.81 28.41 25.20 26.18 -3.74

Procter&Gamble Healt Share Price

5021.30 29.00 (0.58%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×